Guillermo Sanz Mata

Guillermo Sanz Mata is an experienced professional in the field of pharmacovigilance and patient safety, currently serving as Associate Director - Patient Safety Scientist Oncology at AstraZeneca since October 2024. Prior to this role, Guillermo held significant positions at Salvat from June 2022 to September 2024, including Head of Pharmacovigilance and QPPV, as well as Drug Safety Officer and Deputy QPPV. Prior experience includes working as a Drug Safety Officer and Pharmacovigilance trainee at Reig Jofre from January 2019 to June 2022, and as a Farmacéutico and Técnico de farmacia at Farmacia Jimenez Sesma between January 2017 and September 2018. Guillermo holds a Máster in Industria Farmacéutica y Parafarmacéutica from CESIF (2018-2019) and a Grado en Farmacia from Universidad del País Vasco/Euskal Herriko Unibertsitatea.